Preserving visual acuity: a compelling 12-year case study of controlling neovascular age-related macular degeneration.

ABSTRACT:

Introduction

In neovascular age-related macular degeneration (nAMD) trials, anti-VEGF injection frequency decreases after the first year, while outcomes remain primarily related to the number of injections. To the best of our knowledge, there are no reports of maintaining the best corrected visual acuity (BCVA) for more than 7 years in extension studies.

Objective

To report a 12-year follow-up of a real-world case of nAMD where BCVA was preserved from declining.

Case description

A 67-year-old Caucasian female presented to our department in June 2010 due to decreased vision in her left eye (LE) within the preceding months. Examination showed a BCVA of 85 letters (L) in the right eye (RE) and 35 L in the LE. Fundus examination showed drusen in the macula of both eyes. M

SUBMITTER: Tomas RO 

PROVIDER: S-EPMC10946101 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature